Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
Hyperfine, Inc. announced results from a large data set from an investigator-initiated study evaluating stroke detection with t ...
In a retrospective cohort study examining patterns of peripheral artery disease (PAD) diagnosis in United States primary care s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results